Skip to content
Home/Companies/MedTech/Maculaser
MA

Maculaser

MedTech·Finland·Active·0yr hold

Maculaser is a MedTech company, headquartered in Finland.

Entry
2026
Hold
0yr
Status
Active
Est. EV
–

Who owns Maculaser?

Maculaser is currently owned by ZEISS Ventures through ZEISS Ventures CVC (2019 vintage), since 2026.

Hand-verified · updated 2026-07-03

ZEISS Ventures
Investor
ZEISS Ventures
ZEISS Ventures CVC · 2019 · Evergreen

Key facts

HQFinland
SectorMedTech
StatusActive

More from ZEISS Ventures CVC

Other portfolio companies in the same fund.

Custom Surgical
Active
MedTechGermany· 2026
arcoris bio
Active
BiotechSwitzerland· 2025
Lidrotec
Active
Deep TechGermany· 2025
Odne
Active
MedTechSwitzerland· 2025
Surgify Medical
Active
MedTechFinland· 2025
CREAL
Active
Deep TechSwitzerland· 2024

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Aflo
Active
Clarendon Fund ManagersUnited Kingdom
Lattice Medical
Active
Finovam GestionFrance
QTAS
Active
OVNI CapitalGermany
Axomove
Active
Go CapitalFrance· 2026
Bioliberty
Active
Scottish National Investment BankUK· 2026
CertHub
Active
Cusp Capital PartnersGermany· 2026
Data refreshed weekly · Sourced from public filings